Zelnorm™ (tegaserod) – Market re-introduction, updated indication
April 1, 2019 - US WorldMeds announced the FDA approval of Zelnorm (tegaserod), for the treatment of adult women less than 65 years of age with irritable bowel syndrome with constipation (IBS-C).
Download PDF
